Lars Ekman

(Dr. Lars Ekman M.D., Ph.D.)

Currently holds positions in Sophiris Bio Inc, Prothena Corporation PLC, Amarin Corporation PLC, Spark Therapeutics Inc, Ultragenyx Pharmaceutical Inc and InterMune Inc

Positions

Position Company Period
Chairman of the Board Sophiris Bio Inc Jan. 1, 2014 -
Independent Chairman of the Board Prothena Corporation PLC Dec. 1, 2012 -
Independent Chairman of the Board Amarin Corporation PLC Jan. 1, 2014 -
Independent Director Spark Therapeutics Inc May 1, 2014 -
Independent Director Ultragenyx Pharmaceutical Inc March 17, 2016 -
Lead Independent Director InterMune Inc May 13, 2008 -
Independent Director Ocera Therapeutics Inc July 15, 2013 - June 18, 2015
Executive Chairman of the Board Sophiris Bio Inc Oct. 1, 2012 - Jan. 1, 2014
Lead Independent Non-Executive Director Amarin Corporation PLC Oct. 20, 2011 - Jan. 1, 2014
Executive Chairman of the Board, President Sophiris Bio Inc April 18, 2011 - Aug. 1, 2012
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-05 2023-01-03
PS Planned sale
69 -22.1%
60.85
USD 4,198 		69 -22.1% 60.85 USD 4,198
2023-01-05 2023-01-03
PS Planned sale
10 -3.1%
59.46
USD 595 		10 -3.1% 59.46 USD 595
2023-01-05 2023-01-03
PS Planned sale
1,523 -82.5%
58.67
USD 89,353 		1,523 -82.5% 58.67 USD 89,353
2023-01-05 2023-01-03
PS Planned sale
1,303 -41.4%
56.98
USD 74,244 		1,303 -41.4% 56.98 USD 74,244
2023-01-05 2023-01-03
PS Planned sale
6,621 -67.8%
56.33
USD 372,970 		6,621 -67.8% 56.33 USD 372,970
2023-01-05 2023-01-03
PS Planned sale
2,897 -22.9%
55.35
USD 160,341 		2,897 -22.9% 55.35 USD 160,341
2023-01-05 2023-01-03
PS Planned sale
3,411 -21.2%
54.15
USD 184,707 		3,411 -21.2% 54.15 USD 184,707
2022-12-02 2022-12-01
PS Planned sale
6,021 -96.1%
62.12
USD 374,018 		6,021 -96.1% 62.12 USD 374,018
2022-12-02 2022-12-01
PS Planned sale
9,813 -61.0%
61.28
USD 601,388 		9,813 -61.0% 61.28 USD 601,388
2022-11-03 2022-11-01
PS Planned sale
1,661 -87.2%
64.94
USD 107,868 		1,661 -87.2% 64.94 USD 107,868
2022-11-03 2022-11-01
PS Planned sale
3,312 -63.5%
64.26
USD 212,824 		3,312 -63.5% 64.26 USD 212,824
2022-11-03 2022-11-01
PS Planned sale
1,717 -24.8%
62.91
USD 108,013 		1,717 -24.8% 62.91 USD 108,013
2022-11-03 2022-11-01
PS Planned sale
9,143 -56.9%
62.01
USD 566,953 		9,143 -56.9% 62.01 USD 566,953
2022-10-05 2022-10-03
PS Planned sale
1,693 -87.4%
62.96
USD 106,593 		1,693 -87.4% 62.96 USD 106,593
2022-10-05 2022-10-03
PS Planned sale
6,355 -76.6%
62.11
USD 394,677 		6,355 -76.6% 62.11 USD 394,677
2022-10-05 2022-10-03
PS Planned sale
4,277 -34.0%
61.07
USD 261,208 		4,277 -34.0% 61.07 USD 261,208
2022-10-05 2022-10-03
PS Planned sale
3,508 -21.8%
60.32
USD 211,604 		3,508 -21.8% 60.32 USD 211,604
2019-11-07 2019-11-05
PS Planned sale
6,400 -100.0%
18.00
USD 115,230 		6,400 -100.0% 18.00 USD 115,230
2019-09-05 2019-09-03
PS Planned sale
91,016 -100.0%
15.01
USD 1,365,722 		91,016 -100.0% 15.01 USD 1,365,722
2019-03-06 2019-03-04
PS Planned sale
36,700 -100.0%
21.71
USD 796,830 		36,700 -100.0% 21.71 USD 796,830
2019-03-06 2019-03-04
PS Planned sale
98,677 -72.9%
21.16
USD 2,088,074 		98,677 -72.9% 21.16 USD 2,088,074
2019-01-11 2019-01-10
PS Planned sale
7,496 -100.0%
18.62
USD 139,603 		7,496 -100.0% 18.62 USD 139,603
2019-01-11 2019-01-10
PS Planned sale
55,762 -88.2%
18.16
USD 1,012,671 		55,762 -88.2% 18.16 USD 1,012,671
2019-01-11 2019-01-10
PS Planned sale
48,711 -43.5%
17.29
USD 842,140 		48,711 -43.5% 17.29 USD 842,140
2019-01-11 2019-01-10
PS Planned sale
7,247 -6.1%
15.96
USD 115,678 		7,247 -6.1% 15.96 USD 115,678
2019-01-11 2019-01-10
PS Planned sale
21,200 -15.1%
14.92
USD 316,397 		21,200 -15.1% 14.92 USD 316,397
// ... existing code ... // ... rest of the file ...